BRP-020063

N/A

Report date: 2026/05/20 20:02:01
NMEFirst In Class

Base Information

Drug NameBRP-020063
Drug Alias Name¹⁷⁷Lu-BRP-020063⁶⁸Ga-BRP-020063peptide based radiopharmaceutical BRP-020063
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Nuclides > Lutetium > 177LuSmall molecules > Heterocyclic drugs +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Jiao Tong University Affiliated First People'S HospitalBoomRay Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiao Tong University Affiliated First People'S Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A